Update on current and future novel therapies for dry age-related macular degeneration.

Expert review of clinical pharmacology

Volumn 6, Issue 5, 2013, Pages 565-579

  Leung, Ella ^a   Landa, Gennady ^b  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT;

AGING; CLINICAL TRIAL (TOPIC); COMPLEMENT ACTIVATION; DRUG EFFECTS; GEOGRAPHIC ATROPHY; HUMAN; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; VISUAL ACUITY;

AGING; CLINICAL TRIALS AS TOPIC; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; GEOGRAPHIC ATROPHY; HUMANS; OXIDATIVE STRESS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84899614567     PISSN: None     EISSN: 17512441     Source Type: Journal    
DOI: 10.1586/17512433.2013.829645     Document Type: Review

References (0)